In Advancing for ~47 weeks · since 11 Aug 2025stage history
Price10-week line30-week trend line252 trading days
Relative strength vs the F&O universe RS line· baseline 100
The RS line is below its peak and not rising — this stock isn’t out-leading the universe right now, whatever its price is doing.
Returns
3M
+4.2%
6M
+36.3%
9M
+36.1%
12M
+54.2%
52-week range
₹3529₹6028
-9.5% from its 52-week high
Trend-health checklist4/5
✓Price above the 30-week line
✓30-week line is rising
✓10-week line above the 30-week line
✕Price above the 10-week line
✓Strength rank 70 or higher
Extension & risk
Above 30-week line
+10.0%
Close to trend
30-week line (floor)
₹4957
structural floor
Risk back to floor
-9.1%
if it returns there
10-week line
₹5601
nearer support
If price slid back to its 30-week line from here, that is -9.1% — the structural risk this far above the line. These are levels read from the price series, not a buy or sell call.
Futures positioning
Short coveringcurrent-month future · 1 days to expiry
Short covering: futures price up but open interest down — existing shorts buying back to exit. A rise driven by shorts closing, not necessarily fresh demand.
Basis (future vs cash)
+0.37%
premium · ₹21.0
Open interest
-3.7%
vs prior session
Future price
₹5651
cash ₹5630
Futures move
+0.5%
today
Read from the current-month futures contract. Around monthly expiry these reads turn noisy as positions roll to the next series. Descriptive of positioning, not a buy or sell call.
Options positioning
current-month option chain · 28 strikes near the money · 1 days to expiry
ATM implied volatility
6.3%
annualised
Expected move to expiry
±0.3%
~ ±₹18 (1SD)
Put/call ratio (OI)
0.69
by volume 1.05
Max pain
₹5550
ATM ₹5450
Read from the current-month option strikes around the money. Implied volatility is solved from the at-the-money call and put; the expected move is the one-standard-deviation range those prices imply to expiry. Near expiry these compress as time value decays. Descriptive of option pricing, not a buy or sell call.
The 30-week line is computed live from adjusted prices; the checklist is computed from that same series, so chart and score always agree. Educational analysis only — not a recommendation, and not investment advice.